Dr. Joseph Anthony Lanzone Jr., MD

Dr. Lanzone practices at Southeast Georgia Health System-Brunswick Campus in Brunswick, Georgia, part of Southeast Georgia Health System.

Dr. Lanzone's NPI, 1073692174, was assigned on November 2, 2006. Dr. Lanzone graduated from Georgetown University School of Medicine in 1988. Dr. Lanzone holds Georgia license 038283.

Dr. Lanzone's primary practice is Southeast Georgia Health System-Brunswick Campus, at 2415 Parkwood Drive, Brunswick, GA 31520 in Glynn County. The practice phone is (912) 466-7000.

Dr. Lanzone's primary practice is Southeast Georgia Health System-Brunswick Campus in Brunswick, Georgia, part of Southeast Georgia Health System. Dr. Lanzone is also affiliated with Southeast Georgia Health System-Camden Campus. The medical group on file is Southeast Georgia Physician Associates. Dmand AI also links Dr. Lanzone to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lanzone practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Lanzone's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Lanzone is licensed in Georgia.

CMS data shows 2,728 Medicare services from Dr. Lanzone across 21 procedure codes in 2024, for 648 Medicare patients. Medicare paid $134,994 for them.

CMS counts 648 Medicare patients who saw Dr. Lanzone in 2024. The largest group is 75 to 84, with 291 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.25, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lanzone's median patient age at 74, with 26% women.

In 2024, Dr. Lanzone wrote 2,822 Medicare Part D claims for 688 patients. 86% of them were for generic drugs. CMS names the drug for 2,700 of them, across 41 drugs with 11 or more claims each, at $437,499 in total drug cost. In 2023, CMS named 2,268 claims across 36 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 76 out of 100 for Dr. Lanzone for performance year 2024, reported as part of a group. Dr. Lanzone accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Lanzone in 2020. Dr. Lanzone's most frequent co-authors are Kecia Carroll, MD, Tina V. Hartert, MD and Christina Allen Rostad, MD.

CMS Open Payments shows 438 general payments to Dr. Lanzone from 53 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 78% of the total. NeoTract Inc. paid the most, $2,308.

Dr. Lanzone graduated from Georgetown University School of Medicine in 1988.